1. Home
  2. MUX vs VTYX Comparison

MUX vs VTYX Comparison

Compare MUX & VTYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McEwen Mining Inc.

MUX

McEwen Mining Inc.

HOLD

Current Price

$23.80

Market Cap

1.1B

ML Signal

HOLD

Logo Ventyx Biosciences Inc.

VTYX

Ventyx Biosciences Inc.

HOLD

Current Price

$13.87

Market Cap

990.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUX
VTYX
Founded
1979
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Medicinal Chemicals and Botanical Products
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
990.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MUX
VTYX
Price
$23.80
$13.87
Analyst Decision
Strong Buy
Hold
Analyst Count
4
7
Target Price
$21.63
$13.50
AVG Volume (30 Days)
1.3M
5.6M
Earning Date
11-06-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$166,453,000.00
N/A
Revenue This Year
$3.15
N/A
Revenue Next Year
$43.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.38
$0.78
52 Week High
$24.88
$25.00

Technical Indicators

Market Signals
Indicator
MUX
VTYX
Relative Strength Index (RSI) 69.84 75.76
Support Level $21.65 $7.08
Resistance Level $23.00 $13.90
Average True Range (ATR) 1.26 0.41
MACD 0.36 0.25
Stochastic Oscillator 79.97 82.20

Price Performance

Historical Comparison
MUX
VTYX

About MUX McEwen Mining Inc.

McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

Share on Social Networks: